Instalab
logoInstalab

Beta-Hydroxybutyrate

Blood Test
Track ketosis and help detect a diabetic emergency that urine strips can miss.
4.9 (4,591 reviews)
Tested by Quest Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Beta-Hydroxybutyrate test?

This test is most useful if any of these apply to you.

Eating Low-Carb or Keto
Check whether your diet is producing ketosis; the result doesn't measure fat loss or prove that the diet is benefiting you.
Managing Type 1 Diabetes
Blood ketones help guide your sick-day plan and identify possible ketoacidosis alongside glucose and symptoms.
Taking Jardiance or Farxiga
These medicines can cause ketoacidosis with near-normal glucose, making ketone testing useful when symptoms or illness raise concern.
Living With Heart or Liver Disease
Ketones have been linked to outcomes in research, but using this result to guide your heart or liver treatment remains unproven.

About Beta-Hydroxybutyrate

The same ketone result can have very different meanings during a ketogenic diet, a prolonged fast, or an illness with too little insulin. Beta-hydroxybutyrate is an established marker for assessing ketosis and diagnosing and monitoring diabetic ketoacidosis. Its possible use in predicting heart disease, liver outcomes, or longevity is still exploratory.

Your blood level reflects the balance between ketones entering the circulation and tissues using them. It doesn't directly measure how quickly you're burning stored fat. Dietary fat and ketone supplements can also contribute to the result.

What Your Liver Is Doing When This Number Rises

Ketone bodies are small fuel molecules produced mainly by the liver from fatty acids. The three are beta-hydroxybutyrate, acetoacetate, and acetone. BHB is usually the most abundant in blood, particularly during ketoacidosis.

Your liver produces ketones for other tissues, including the brain, heart, and muscles. It lacks a key enzyme needed to use them through the usual ketone-burning pathway. Insulin suppresses the release of fatty acids from fat tissue and reduces the liver's ketone production, which helps explain why BHB generally falls after eating and rises during fasting or carbohydrate restriction.

This test measures D-BHB in serum separated from a venous blood draw, using an enzyme-based laboratory assay. D-BHB is the form your liver mainly produces. Results are reported in mmol/L, a unit of concentration. Routine clinical blood testing can also use plasma, but whole-blood meter readings and research measurements require attention to their own methods.

BHB also affects cell signaling. Experiments in cells and animals have found effects on gene activity and inflammatory responses. Those findings help explain scientific interest in ketones, but they don't establish that raising your blood level slows aging or prevents disease.

Diabetic Ketoacidosis

Diabetic ketoacidosis develops when insufficient insulin allows excessive ketone production and acid accumulation. It can cause severe dehydration and dangerous disturbances in the body's salts. Total potassium stores are often depleted even when the initial blood potassium result is normal or high.

BHB is central to diagnosis, but ketoacidosis also requires evidence that the blood has become too acidic. Blood pH and bicarbonate provide that information. Glucose may be only mildly raised or near normal, particularly with SGLT2 inhibitors, so a reassuring glucose reading cannot exclude the condition.

Urine ketone strips detect acetoacetate and do not detect BHB. They can underestimate ketosis early in DKA. During recovery, BHB converts back into acetoacetate, so urine ketones may remain positive or appear to increase while the condition improves.

Clinical guidance recommends direct blood BHB measurement for diagnosing and monitoring DKA. Both laboratory testing and suitable finger-stick blood meters have a role. A systematic review of small studies in type 1 diabetes found advantages for blood testing in hospital use, recovery time, and costs. Much of that evidence involved capillary testing in children and young people; it doesn't establish that a scheduled venous draw provides the same benefits as timely sick-day testing.

Heart Disease, Heart Failure, and Earlier Death

Several large population studies have linked higher circulating ketones with later heart failure and death. The three studies below measured total ketone bodies in plasma using nuclear magnetic resonance, or NMR. NMR identifies chemicals through their magnetic signals. Total ketones include BHB, acetoacetate, and acetone, so these findings concern a related measurement rather than this serum D-BHB result alone.

Who Was StudiedWhat Was ComparedWhat They Found
About 91,000 UK adults without cardiovascular disease or heart failure, followed for about 13 yearsA tenfold difference in total plasma ketonesAbout 50% higher mortality, 44% higher heart-failure incidence, and 31% higher atherosclerotic cardiovascular disease incidence after adjustment; heart attacks alone were not significantly associated
About 6,800 US adults in MESA, followed for about 14 yearsA tenfold difference in total plasma ketonesAbout 80% higher mortality and 70% higher heart-failure incidence after adjustment
About 1,750 US adults aged 65 and older in the Cardiovascular Health Study, followed for up to 20 yearsThe highest fifth of total plasma ketones versus the lowest fifthAbout 50% higher mortality; the study also found a heart-failure association using a separate continuous analysis

These are relative associations across groups, not estimates of what a particular BHB result means for you. Sampling conditions differed between studies, and the studies weren't designed to isolate intentional ketogenic diets. They don't establish that ketones caused the adverse outcomes or that lowering BHB would prevent them.

Studies measuring BHB alone have been less consistent. In about 6,100 Dutch adults followed for roughly eight years, an association with new heart failure weakened after established cardiac risk markers were included. Associations differed between women and men. A separate study of about 3,000 Chinese adults undergoing coronary angiography linked higher serum BHB with more severe coronary artery disease, particularly in women. That selected population cannot establish its value as a screening test in healthy adults.

These findings support studying ketones as markers of metabolic stress. They haven't established a BHB-based cardiovascular risk score, a preventive treatment target, or a benefit from routine screening.

When Heart Disease Is Already Present

In 478 people with chronic heart failure, higher plasma BHB measured by NMR was associated with higher mortality. Statistical analyses suggested that protein patterns linked to inflammation and tissue breakdown accounted for about three quarters of the association. Such analyses cannot prove that those processes caused the relationship.

In another study of 867 people with advanced heart failure, plasma BHB rose with circulating fatty acids and worse heart pressures. Its association with outcomes disappeared after fatty acids were taken into account. This supports the possibility that BHB reflects the metabolic changes accompanying heart failure, but it doesn't settle whether ketones themselves help or harm the failing heart.

Other findings come from narrowly defined clinical settings. In a retrospective study of surgery for an aortic dissection, major postoperative events occurred in about 32% of the higher-BHB group and 5% of the lower-BHB group. The combined outcome included death, stroke, and other serious complications. Plasma BHB has also been associated with outcomes and disease progression in arrhythmogenic cardiomyopathy, including among initially asymptomatic relatives. Neither study establishes a screening strategy for the general population.

Why a High Number Can Mean Different Things

Fasting, dietary carbohydrate restriction, insulin deficiency, and illness can all increase ketones through different combinations of fat release, liver production, and tissue use. In heart failure, increased ketones may also be part of the body's response to altered energy demands. A high concentration alone doesn't identify which process is responsible.

Population associations therefore cannot be applied directly to ketosis deliberately produced by a diet. They establish neither the long-term safety nor the long-term harm of that dietary state.

Diabetes Risk and Insulin Function

In 369 people with newly diagnosed type 2 diabetes, higher serum BHB was associated with worse starting blood glucose and measures of lower insulin secretion. Those with higher BHB also had greater HbA1c improvement after six months of treatment. This observational finding doesn't show that higher ketones caused the improvement.

In 453 Korean adults with impaired fasting glucose followed for nearly 11 years, serum BHB did not reliably predict progression to diabetes after adjustment. BHB therefore cannot replace glucose or HbA1c for assessing diabetes risk, and neither a fasting insulin result nor HbA1c alone can establish why your ketones are raised.

Liver Cirrhosis

One study found plasma BHB about 20% lower in people with cirrhosis than in matched controls. Within the cirrhosis group, the highest third had an estimated death rate about eight times that of the middle third. The estimate was imprecise: the study included 125 people and 27 deaths. The apparent increase at the lowest levels was not statistically reliable.

These measurements used plasma NMR. The findings suggest altered ketone metabolism in cirrhosis, but they don't establish that a low BHB result means your liver cannot produce enough ketones, or that either end of the distribution is a treatment target.

Alzheimer's Disease

In about 262,000 UK adults, plasma BHB measured by NMR did not independently predict Alzheimer's disease after adjustment. The study explored differences by genetic risk, but it doesn't support using this test to estimate your dementia risk.

When Results Can Be Misleading

BHB changes substantially with recent food intake and energy use. A small study that sampled 12 healthy adults on consecutive mornings found considerable variation within the same person, even under fasting conditions. A single result may not represent your usual level.

  • Fasting, reduced eating, and illness: Longer periods without food generally raise BHB. Vomiting, infection, and heavy alcohol use with poor food intake can also raise it. These are real biological changes, and illness-related ketosis may require medical assessment.
  • Recent exercise: Exercise during a prolonged fast can temporarily increase BHB. That response doesn't establish that your usual fasting level has changed.
  • Ketone products and MCT oil: Ketone drinks can temporarily raise circulating BHB. MCT oil supplies fats that the liver can convert into ketones. These effects can make a result unsuitable for judging whether your usual diet is producing ketosis.
  • Hormones and medications: Population research using plasma NMR has associated BHB with age, menopausal status, oral contraceptive use, and beta-blocker use. These associations don't establish a predictable correction for an individual result. SGLT2 inhibitors can cause a clinically meaningful increase in ketoacidosis risk.
  • Differences between methods: Finger-stick meters measure capillary whole blood, while this laboratory test measures serum. Differences depend on the device, concentration, and sampling conditions. A small study found higher capillary results, but there is no universal percentage conversion between home and laboratory measurements.
  • Which form is measured: Some ketone supplements contain both D-BHB and L-BHB. This enzyme-based test measures D-BHB, so it doesn't represent the combined amount of both forms after such a product.
  • Analytical variation and sample quality: Small differences at low concentrations may reflect measurement variation. Severe breakdown of red blood cells can make a specimen unsuitable for testing.

What Moves This Biomarker

Evidence-backed interventions that affect your Beta-Hydroxybutyrate level

↓ Decrease
Insulin treatment for diabetic ketoacidosis
Insulin suppresses fat release and liver ketone production, lowering BHB as ketoacidosis resolves. Treatment also requires fluids and careful electrolyte management; insulin alone is not a complete DKA treatment plan.
MedicationStrong Evidence
↑ Increase
Clinically supervised ketogenic dietary therapy
Sustained carbohydrate restriction raises BHB and can maintain therapeutic ketosis. Ketogenic dietary therapy benefits some people with drug-resistant epilepsy. The desirable change applies when ketosis serves a defined treatment goal; a higher BHB result alone doesn't establish better health or greater fat loss.
DietStrong Evidence
↑ Increase
Sotagliflozin added to insulin in type 1 diabetes trials
Sotagliflozin produced a small rise in median fasting blood BHB over 24 weeks and increased the risk of diabetic ketoacidosis. Higher starting BHB and larger increases were associated with greater DKA risk. Ketoacidosis can occur even when glucose is near normal.
MedicationModest Evidence

Frequently Asked Questions

References

36 studies
  1. Guillermo E. Umpierrez, Georgia M. Davis, Nuha a. Elsayed, Gian Paolo Fadini, Rodolfo J. Galindo, Irl B. Hirsch, David C. Klonoff, Rozalina G. Mccoy, Shivani Misra, Robert a. Gabbay, Raveendhara R. Bannuru, Ketan K. DhatariyaDiabetologia2024
  2. David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea R. Horvath, ÅKe Lernmark, Boyd E. Metzger, David M. Nathan, M. Sue KirkmanDiabetes Care2023
  3. Mayo Clinic LaboratoriesMayo Clinic Laboratories2026
  4. Jingtong Kaya Huang, Andrea M. Yeung, Richard M. Bergenstal, Kristin N. Castorino, Eda Cengiz, Ketan Dhatariya, Isabella Niu, Jennifer L. Sherr, Guillermo E. Umpierrez, David Charles KlonoffJournal of Diabetes Science and Technology2023

Beta-Hydroxybutyrate Test

$119
FSA/HSA eligible
No Rx needed
HIPAA compliant